Prescription drug · ANDA
Tobramycin Inhalation Solution NDC 16714-119
Tobramycin 300 mg/5mL · Inhalant · Respiratory (Inhalation) · NorthStar RxLLC
NDC codes
FDA NDC DirectoryProduct information
- Brand name (proprietary)
- Tobramycin Inhalation Solution
- Generic name (nonproprietary)
- tobramycin inhalation solution
- Active ingredients
- Tobramycin — 300 mg/5mL
- Dosage form
- Inhalant
- Route
- Respiratory (Inhalation)
- Labeler
- NorthStar RxLLCNDC labeler code 16714
- Product type
- Prescription drug
- Marketing category
- ANDA — Abbreviated New Drug Application (generic)Application ANDA 207080
- Marketing start
- Listing expires
- Other FDA classes
- Aminoglycosides (Chemical structure)
- Identifiers
- Product ID 16714-119_6502d04c-fcb7-fa1f-2ca5-33cbc66ffe9bSPL ID 6502d04c-fcb7-fa1f-2ca5-33cbc66ffe9bSPL set ID 3d044738-a715-fdee-7849-521e8981e6ecRxCUI 348719UNII VZ8RRZ51VKUPC 0316714119021
- Pharmacologic class
- Aminoglycoside Antibacterial
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.
Product label
Current FDA label (SPL), effective .
Indications (excerpt from the label)
Tobramycin inhalation solution is indicated for the management of cystic fibrosis in adults and pediatric patients 6 years of age and older with Pseudomonas aeruginosa. Safety and efficacy have not been demonstrated in patients under the age of 6 years, patients with forced expiratory volume in 1 second (FEV 1 ) <25% or >75% predicted, or patients colonized with Burkholderia cepacia [see Clinical Studies ( 14 ) ]. Tobramycin inhalation solution is an aminoglycoside antibacterial indicated for the management of cystic fibrosis in adults and pediatric patients 6 years of age and older with Pseudomonas aeruginosa . ( 1 ) Safety and efficacy have not been demonstrated in patients under the age o…
Excerpt only. Read the full label for complete information.
About NDC 16714-119
- What is NDC 16714-119?
- 16714-119 is the product NDC for Tobramycin Inhalation Solution, Tobramycin 300 mg/5mL inhalant, listed with the FDA by NorthStar RxLLC.
- What drug is associated with this NDC?
- Tobramycin Inhalation Solution.
- What is the active ingredient?
- Tobramycin.
- Who is the labeler?
- NorthStar RxLLC, NDC labeler code 16714. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
- What other NDCs exist for Tobramycin Inhalation Solution?
- 1 other product NDC are listed under this name. See all Tobramycin Inhalation Solution NDCs.
- Is there a related HCPCS / J-code?
- Not in Med-Code's curated HCPCS directory. See Billing references above.
Related NDCs: other Tobramycin Inhalation Solution products
Other finished products listed under the same name: strengths, forms and labelers.
| Product | Strength | Form · route | Labeler | Product NDC | Package NDCs (11-digit) |
|---|---|---|---|---|---|
| Tobramycin Inhalation Solution | Tobramycin 300 mg/5mL | InhalantRespiratory (Inhalation) | Dr. Reddy's Laboratories Inc. | 43598-605 | 43598-0605-5643598-0605-58 |
Other NDCs under ANDA 207080
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Tobramycin Inhalation Solution | Tobramycin 300 mg/5mL | InhalantRespiratory (Inhalation) | Dr. Reddy's Laboratories Inc. | 43598-605 |